Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024
Union Korea Pharm Revenue
Union Korea Pharm had revenue of 7.13B KRW in the quarter ending September 30, 2025, a decrease of -54.80%. This brings the company's revenue in the last twelve months to 33.83B, down -47.22% year-over-year. In the year 2024, Union Korea Pharm had annual revenue of 51.28B, down -18.82%.
Revenue (ttm)
33.83B
Revenue Growth
-47.22%
P/S Ratio
0.58
Revenue / Employee
203.80M
Employees
166
Market Cap
19.70B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WooGene B&G | 54.77B |
| Kwangdong Healthbio | 38.10B |
| BIFIDO | 18.65B |
| Daesung Microbiological Labs. | 25.86B |
| Future Medicine | 1.00B |
| ChoA Pharmaceutical Co., LTD. | 60.50B |
| Pharmsville | 13.36B |
| Hurum | 95.37B |